Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ahye Cho"'
Autor:
Yoon-La Choi, Joon Oh Park, Ahye Cho, Joshua M. Francis, Kyoung-Mee Kim, Angela K.J. Park, JaeHyung Koo, Meraj Aziz, Je-Gun Joung, Michelle Kassner, Woong-Yang Park, Myung-Ju Ahn, Hideo Watanabe, Jeonghee Cho, Nayoung Kim, Hongwei Holly Yin, Joon Seol Bae, Keunchil Park, Soo Min Ahn
Publikováno v:
Oncotarget
Therapies targeting the tyrosine kinase activity of Epidermal Growth Factor Receptor (EGFR) have been proven to be effective in treating a subset of non-small cell lung cancer (NSCLC) patients harboring activating EGFR mutations. Inevitably these pat
Autor:
Jarrod A. Marto, Rameen Beroukhim, Angela K.J. Park, Ahye Cho, Yi Zhang, Bradley A. Murray, Kihong Kim, Byung Il Lee, Michael J. Eck, Scott B. Ficarro, Nayoung K.D. Kim, Woong-Yang Park, Eun Young Park, Jeonghee Cho, Matthew Meyerson
Publikováno v:
Nature structural & molecular biology
Mig6 is a feedback inhibitor that directly binds, inhibits and drives internalization of ErbB-family receptors. Mig6 selectively targets activated receptors. Here we found that the epidermal growth factor receptor (EGFR) phosphorylates Mig6 on Y394 a
Autor:
Kyoung-Mee Kim, Yoon-La Choi, J. O. Park, Angela Kj Park, Keunchil Park, Meraj Aziz, Ahye Cho, Nayoung K.D. Kim, Joshua M. Francis, Joon Seol Bae, Hongwei Holly Yin, Soomin Ahn, Michelle Kassner, Myung-Ju Ahn, Hideo Watanabe, Jeonghee Cho, Je-Gun Joung, Woong-Yang Park
Publikováno v:
Cancer Research. 76:2931-2931
Therapies targeting the tyrosine kinase activity of Epidermal Growth Factor Receptor (EGFR) have been proven to be effective in treating a subset of non-small cell lung cancer (NSCLC) patients harboring activating EGFR mutations. Inevitably these pat
Autor:
Jeonghee Cho, Shi Nai Lee, Stacey Gabriel, Panisa Pochanard, Ahye Cho, Douglas Voet, Nayoung K.D. Kim, Nikhil Wagle, Angela K.J. Park, Mai Yamauchi, Jose Jimenez, Michael S. Lawrence, Carrie Sougnez, Adam J. Bass, Woong-Yang Park, Heidi Greulich, Eric S. Lander, Matthew Meyerson, Shuji Ogino, Jonghwa Won, Gad Getz, Jose Baselga, Josep Tabernero, Kristian Cibulskis, Michael J. Eck, Hyung Suk Hur
Publikováno v:
BioMed Central Ltd
Molecular Cancer
Molecular Cancer
Background: Inhibition of the activated epidermal growth factor receptor (EGFR) with either enzymatic kinase inhibitors or anti-EGFR antibodies such as cetuximab, is an effective modality of treatment for multiple human cancers. Enzymatic EGFR inhibi